Manith Norng

655 total citations
9 papers, 232 citations indexed

About

Manith Norng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Manith Norng has authored 9 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Manith Norng's work include Inflammation biomarkers and pathways (2 papers), Immune cells in cancer (2 papers) and Cell death mechanisms and regulation (1 paper). Manith Norng is often cited by papers focused on Inflammation biomarkers and pathways (2 papers), Immune cells in cancer (2 papers) and Cell death mechanisms and regulation (1 paper). Manith Norng collaborates with scholars based in United States. Manith Norng's co-authors include Jianyuan Chai, Jing Zhang, Jennifer Chow, Andrzej S. Tarnawski, Kevin M. Reavis, Jennifer Pham, Michael K. Jones, Vuong Trieu, Neil Desai and Editte Gharakhanian and has published in prestigious journals such as Cancer Research, Gut and Journal of Cellular Physiology.

In The Last Decade

Manith Norng

9 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manith Norng United States 5 132 77 30 26 24 9 232
Lucile Noyer United States 9 113 0.9× 124 1.6× 16 0.5× 35 1.3× 18 0.8× 15 255
Hanxing Wan China 11 164 1.2× 134 1.7× 55 1.8× 23 0.9× 24 1.0× 24 339
Charbel El Boustany France 6 207 1.6× 166 2.2× 25 0.8× 27 1.0× 18 0.8× 7 340
Pilong Shi China 10 161 1.2× 40 0.5× 37 1.2× 26 1.0× 14 0.6× 11 331
Fengna Yan China 9 92 0.7× 34 0.4× 25 0.8× 71 2.7× 56 2.3× 13 274
Liping Wu China 7 155 1.2× 24 0.3× 12 0.4× 30 1.2× 19 0.8× 18 261
Avani R. Vyas United States 9 209 1.6× 19 0.2× 10 0.3× 36 1.4× 47 2.0× 10 331
Zhongheng Sui China 6 124 0.9× 21 0.3× 13 0.4× 17 0.7× 19 0.8× 6 244
Sima Mansoori Derakhshan Iran 11 196 1.5× 32 0.4× 17 0.6× 42 1.6× 40 1.7× 35 369
Tiantian Zhao Canada 10 169 1.3× 18 0.2× 11 0.4× 34 1.3× 13 0.5× 13 312

Countries citing papers authored by Manith Norng

Since Specialization
Citations

This map shows the geographic impact of Manith Norng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manith Norng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manith Norng more than expected).

Fields of papers citing papers by Manith Norng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manith Norng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manith Norng. The network helps show where Manith Norng may publish in the future.

Co-authorship network of co-authors of Manith Norng

This figure shows the co-authorship network connecting the top 25 collaborators of Manith Norng. A scholar is included among the top collaborators of Manith Norng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manith Norng. Manith Norng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Vuong, Christine N., Kevin A. Reynolds, Manith Norng, et al.. (2024). Heavy chain-only antibodies with a stabilized human VH in transgenic chickens for therapeutic antibody discovery. mAbs. 16(1). 2435476–2435476. 3 indexed citations
2.
Mayes, Erin, Mikhail Binnewies, Pamela Canaday, et al.. (2021). Abstract P104: Therapeutic targeting of TREM1 with PY159 promotes myeloid cell reprogramming and unleashes anti-tumor immunity. Molecular Cancer Therapeutics. 20(12_Supplement). P104–P104. 1 indexed citations
3.
Binnewies, Mikhail, Tiep Le, Joshua L. Pollack, et al.. (2019). Abstract C104: Therapeutic targeting of TREM2+ tumor-associated macrophages as a means of overcoming checkpoint inhibitor resistance. Molecular Cancer Therapeutics. 18(12_Supplement). C104–C104. 2 indexed citations
4.
Chai, Jianyuan, et al.. (2010). CCN1 induces a reversible epithelial–mesenchymal transition in gastric epithelial cells. Laboratory Investigation. 90(8). 1140–1151. 27 indexed citations
5.
Hwang, Lindsay, et al.. (2009). Albumin-Binding and Angiogenic Domains of SPARC Located at Its C-Terminus.. Cancer Research. 69(24_Supplement). 2144–2144. 5 indexed citations
7.
Norng, Manith, et al.. (2007). TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells—Mechanisms behind a possible new “hot” cancer treatment. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773(4). 565–576. 127 indexed citations
8.
Chai, Jianyuan, Manith Norng, Andrzej S. Tarnawski, & Jennifer Chow. (2006). A critical role of serum response factor in myofibroblast differentiation during experimental oesophageal ulcer healing in rats. Gut. 56(5). 621–630. 45 indexed citations
9.
Gharakhanian, Editte, et al.. (2004). Cys254 and Cys49/Cys87of simian virus 40 Vp1 are essential in formation of infectious virions. Virus Research. 107(1). 21–25. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026